All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

The MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

Visual abstract | Phenotype and survival outcomes in Black African American patients with PMF

Apr 21, 2023
Learning objective: After reading this article, learners will be able to cite a new clinical development in myelofibrosis.

The MPN Hub is pleased to present a visual abstract comparing the clinical genotype, phenotype, and long-term survival outcomes of Black African American patients diagnosed with primary myelofibrosis to their non-African American counterparts. This multicenter, first-of-its-kind study was recently published in Blood Advances by Gangat et al.1

Visual Abstract

To download this visual abstract, click below.

Download here

  1. Gangat N, Kuykendall AT, Al Ali NH, et al. Black African American patients with primary myelofibrosis: A comparative analysis of phenotype and survival. Blood Adv. Online ahead of print. DOI: 10.1182/bloodadvances.2022009611

Your opinion matters

How would you define myelofibrosis treatment failure? A. A lack of spleen reduction B. A lack of symptom reduction C. A lack of either spleen or symptom reduction D. Symptom relief deemed inadequate by the patient
2 votes - 15 days left ...


Subscribe to get the best content related to MPN delivered to your inbox